Candel therapeutics presents preclinical data from its enlighten™ discovery platform at sitc

Needham, mass., nov. 04, 2023 (globe newswire) -- candel therapeutics, inc. (the company or candel) (nasdaq: cadl), a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight cancer, today will present two posters during the 2023 society for immunotherapy of cancer (sitc) annual meeting in san diego focused on the enlighten™ discovery platform.
CADL Ratings Summary
CADL Quant Ranking